Oppenheimer Asset Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $891K | Buy |
57,613
+2,147
| +4% | +$33.2K | 0.01% | 768 |
|
2025
Q1 | $825K | Sell |
55,466
-3,585
| -6% | -$53.3K | 0.01% | 760 |
|
2024
Q4 | $782K | Sell |
59,051
-138,148
| -70% | -$1.83M | 0.01% | 779 |
|
2024
Q3 | $2.8M | Sell |
197,199
-56,430
| -22% | -$802K | 0.03% | 457 |
|
2024
Q2 | $3.28M | Buy |
253,629
+22,979
| +10% | +$297K | 0.04% | 407 |
|
2024
Q1 | $3.2M | Buy |
230,650
+13,586
| +6% | +$189K | 0.05% | 367 |
|
2023
Q4 | $3.1M | Sell |
217,064
-26,521
| -11% | -$378K | 0.04% | 406 |
|
2023
Q3 | $3.77M | Sell |
243,585
-6,175
| -2% | -$95.5K | 0.06% | 338 |
|
2023
Q2 | $3.92M | Sell |
249,760
-4,120
| -2% | -$64.7K | 0.06% | 336 |
|
2023
Q1 | $4.18M | Sell |
253,880
-9,538
| -4% | -$157K | 0.06% | 304 |
|
2022
Q4 | $4.11M | Sell |
263,418
-30,548
| -10% | -$477K | 0.07% | 310 |
|
2022
Q3 | $3.81M | Sell |
293,966
-1,044
| -0.4% | -$13.5K | 0.07% | 293 |
|
2022
Q2 | $4.14M | Sell |
295,010
-15,440
| -5% | -$217K | 0.07% | 293 |
|
2022
Q1 | $4.45M | Buy |
310,450
+21,926
| +8% | +$314K | 0.06% | 317 |
|
2021
Q4 | $3.93M | Sell |
288,524
-131,993
| -31% | -$1.8M | 0.05% | 359 |
|
2021
Q3 | $6.89M | Sell |
420,517
-21,490
| -5% | -$352K | 0.1% | 243 |
|
2021
Q2 | $7.44M | Buy |
442,007
+62,104
| +16% | +$1.05M | 0.11% | 224 |
|
2021
Q1 | $6.94M | Buy |
379,903
+33,858
| +10% | +$618K | 0.11% | 220 |
|
2020
Q4 | $6.3M | Buy |
346,045
+25,302
| +8% | +$460K | 0.11% | 230 |
|
2020
Q3 | $5.72M | Sell |
320,743
-8,478
| -3% | -$151K | 0.11% | 214 |
|
2020
Q2 | $5.9M | Sell |
329,221
-62,667
| -16% | -$1.12M | 0.12% | 201 |
|
2020
Q1 | $5.95M | Sell |
391,888
-34,914
| -8% | -$530K | 0.15% | 168 |
|
2019
Q4 | $8.42M | Sell |
426,802
-19,047
| -4% | -$376K | 0.18% | 140 |
|
2019
Q3 | $7.67M | Buy |
445,849
+7,825
| +2% | +$135K | 0.17% | 152 |
|
2019
Q2 | $7.75M | Buy |
438,024
+53,616
| +14% | +$949K | 0.17% | 146 |
|
2019
Q1 | $7.83M | Buy |
384,408
+74,247
| +24% | +$1.51M | 0.18% | 146 |
|
2018
Q4 | $5.22M | Buy |
+310,161
| New | +$5.22M | 0.13% | 190 |
|